A clinical trial update dated July 13, 2026 reports that the study titled "Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation" has changed status to active, not recruiting. The trial is registered under identifier NCT06855758. Its listed phase is not applicable. The study focuses on intraoperative blood pressure management during kidney transplantation procedures.
This update reflects only a change in recruitment status, not the availability or reporting of any results. No efficacy or safety outcomes are included in this update. The trial record does not state when results might be posted or what endpoints are being measured beyond the title description.
Lypressin, related to terlipressin, remains classified as unapproved for research use in this context. Readers should note that trial status changes such as this one indicate progress in study logistics, such as completion of enrollment, rather than any conclusions about the intervention. Further updates to this trial may be issued as its status changes.
For additional background on this compound, readers can consult the compound overview page.